A study from Massachusetts General Hospital (MGH) investigators sheds new light on how the hallmarks of Alzheimer's disease—amyloid-beta (A-beta) plaques and neurofibrillary tangles containing the protein tau—produce their damaging effects in the brain. The findings suggest that strategies directed against both pathologic proteins, rather than one or the other, might be promising therapeutic options.
from Medical Xpress - latest medical and health news stories https://ift.tt/2LreztP
via IFTTT
No comments:
Post a Comment